Seeing Is Believing

Currently out of the existing stock ratings of Evan Seigerman, 295 are a BUY (66.44%), 124 are a HOLD (27.93%), 25 are a SELL (5.63%).
Analyst Evan Seigerman, currently employed at BMO, carries an average stock price target met ratio of 73.2% that have a potential upside of 33.86% achieved within 284 days.
Evan Seigerman’s has documented 886 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on AMGN, Amgen.
Analyst best performing recommendations are on PTGX (PROTAGONIST THERAPEUTICS).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 10/8/2025. The price target of $72 was fulfilled within 2 days with a profit of $6.7 (10.26%) receiving and performance score of 51.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Sep-2023
2 years 9 months 5 days ago
(07-Dec-2023)
0/2 (0%)
$68.1 (94.71%)
Buy Since 05-Nov-2018
$4
$2.87 (253.98%)
$9
4 years 9 months 11 days ago
(01-Dec-2021)
2/2 (100%)
$-8.43 (-67.82%)
670
Buy Since 16-Aug-2018
$4
$2.87 (253.98%)
$7
5 years 5 months 27 days ago
(16-Mar-2021)
3/3 (100%)
$-33.2 (-89.25%)
1106
Sell Since 13-Aug-2020
$16.6
$15.47 (1369.03%)
$16.8
5 years 10 months 6 days ago
(06-Nov-2020)
4/4 (100%)
$-12.4 (-42.76%)
335
Buy Since 09-May-2019
$120
$118.87 (10519.47%)
7 years 4 months 3 days ago
(09-May-2019)
0/1 (0%)
$56.4 (88.68%)
Which stock is Evan Seigerman most bullish on?
Which stock is Evan Seigerman most reserved on?
What Year was the first public recommendation made by Evan Seigerman?